Provided herein are compositions and methods for the treatment of cancer by inhibition of ß-catenin or a ß-catenin pathway. In particular, inhibitors of ß-catenin and/or the Wnt/p-catenin signaling pathway are employed prevent or reverse evasion of immune response or immunotherapy by cancers.